Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

FDA approves Janssen’s Yondelis

Provides additional treatment option for softtissue sarcoma

- PMLiVE

Merck and MacroGenics collaborate on immuno-oncology

Evaluates margetuximab with Keytruda for gastric cancer

- PMLiVE

Is Pfizer eyeing a merger with Allergan?

Combined company value could be $330bn

- PMLiVE

Jane Osbourn to chair BIA board

VP of R&D atMedimmune to chair BioIndustry Association board

- PMLiVE

dna boosts London offering

Healthcarecomms agency launches specialist PR unit

- PMLiVE

Clark Health Communications in Farringdon move

Expands into new London offices

- PMLiVE

AstraZeneca backs heart website

Works with charity HEART UK on How Young My Heart

Bristol-Myers Squibb (BMS) building

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales

Supports analysts prediction BMS' Opdivo will become market leader

- PMLiVE

Amgen gets FDA nod for virus-based melanoma therapy

Advisory committee votes in favour of drug after three month delay

- PMLiVE

Ardelyx appoints William Bertrand Jr to board of directors

Executive VP of Infinity Pharmaceuticals joins the team

- PMLiVE

Consultation begins on new patient access scheme

EMA hopes PRIME will improve development of prioritymedicines and ease access concerns

- PMLiVE

Vertex forges ties with gene editing firm CRISPR Therapeutics

Aims to find new treatments for genetic diseases such as cystic fibrosis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links